| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |